# NexMetals Mining Corp.: financial statements, quarterly

NEXM · Nasdaq · CIK 795800 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nexm.md) · [Financials](/companies/nexm/financials.md) · [Filings](/companies/nexm/filings.md) · [Insiders](/companies/nexm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nexm/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Selling, general and administrative | $m | not reported | not reported | [0.9](/filings/0001641172-25-010011.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(7.7)](/filings/0001493152-24-046023.md) | [(10.2) d](/filings/0001641172-25-000043.md) | [(9.3)](/filings/0001641172-25-010011.md) | [(9.8)](/filings/0001493152-25-011913.md) | [(12.0)](/filings/0001493152-25-022391.md) | [(11.3) d](/filings/0001493152-26-022760.md) | [(15.2)](/filings/0001493152-26-022779.md) | [(15.1)](/filings/0001493152-26-038782.md) | [(16.0)](/filings/0001493152-25-022391.md) | [(12.8) d](/filings/0001493152-26-022760.md) | [(10.6)](/filings/0001493152-26-022779.md) | [(11.9)](/filings/0001493152-26-038782.md) |
| Diluted EPS | $ per share | [0.06](/filings/0001493152-24-046023.md) | not reported | [0.06](/filings/0001641172-25-010011.md) | [1.26](/filings/0001493152-25-011913.md) | [1.29](/filings/0001493152-25-022391.md) | not reported | [1.36](/filings/0001493152-26-022779.md) | [0.70](/filings/0001493152-26-038782.md) | [0.75](/filings/0001493152-25-022391.md) | not reported | [0.30](/filings/0001493152-26-022779.md) | [0.33](/filings/0001493152-26-038782.md) |
| Basic EPS | $ per share | [0.06](/filings/0001493152-24-046023.md) | not reported | [0.06](/filings/0001641172-25-010011.md) | [1.26](/filings/0001493152-25-011913.md) | [1.29](/filings/0001493152-25-022391.md) | not reported | [1.36](/filings/0001493152-26-022779.md) | [0.70](/filings/0001493152-26-038782.md) | [0.75](/filings/0001493152-25-022391.md) | not reported | [0.30](/filings/0001493152-26-022779.md) | [0.33](/filings/0001493152-26-038782.md) |

- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [19.2](/filings/0001641172-25-000043.md) | [9.4](/filings/0001104659-24-079535.md) | [28.1](/filings/0001493152-24-033164.md) | [17.4](/filings/0001493152-24-046023.md) | [6.1](/filings/0001493152-26-022760.md) | [45.5](/filings/0001641172-25-010011.md) | [26.5](/filings/0001493152-25-011913.md) | [14.1](/filings/0001493152-25-022391.md) | [39.8](/filings/0001493152-26-038782.md) | [26.2](/filings/0001493152-26-022779.md) | [17.0](/filings/0001493152-26-038782.md) |
| Current assets | $m | not reported | [20.7](/filings/0001641172-25-000043.md) | [11.8](/filings/0001104659-24-079535.md) | [30.9](/filings/0001493152-24-033164.md) | [20.7](/filings/0001493152-24-046023.md) | [7.6](/filings/0001493152-26-022760.md) | [46.7](/filings/0001641172-25-010011.md) | [29.4](/filings/0001493152-25-011913.md) | [16.5](/filings/0001493152-25-022391.md) | [46.5](/filings/0001493152-26-038782.md) | [30.5](/filings/0001493152-26-022779.md) | [18.7](/filings/0001493152-26-038782.md) |
| Total assets | $m | not reported | [38.0](/filings/0001641172-25-000043.md) | [28.5](/filings/0001104659-24-079535.md) | [47.5](/filings/0001493152-24-033164.md) | [37.3](/filings/0001493152-24-046023.md) | [25.0](/filings/0001493152-26-022760.md) | [63.8](/filings/0001641172-25-010011.md) | [47.1](/filings/0001493152-25-011913.md) | [34.0](/filings/0001493152-25-022391.md) | [98.5](/filings/0001493152-26-038782.md) | [81.1](/filings/0001493152-26-022779.md) | [70.7](/filings/0001493152-26-038782.md) |
| Current liabilities | $m | not reported | [5.9](/filings/0001641172-25-000043.md) | [5.1](/filings/0001104659-24-079535.md) | [5.6](/filings/0001493152-24-033164.md) | [5.6](/filings/0001493152-24-046023.md) | [4.2](/filings/0001493152-26-022760.md) | [7.3](/filings/0001641172-25-010011.md) | [5.5](/filings/0001493152-25-011913.md) | [6.5](/filings/0001493152-25-022391.md) | [10.0](/filings/0001493152-26-038782.md) | [3.9](/filings/0001493152-26-022779.md) | [3.6](/filings/0001493152-26-038782.md) |
| Total liabilities | $m | not reported | [28.2](/filings/0001641172-25-000043.md) | [27.8](/filings/0001104659-24-079535.md) | [28.9](/filings/0001493152-24-033164.md) | [29.6](/filings/0001493152-24-046023.md) | [28.4](/filings/0001493152-26-022760.md) | [12.2](/filings/0001641172-25-010011.md) | [10.5](/filings/0001493152-25-011913.md) | [12.4](/filings/0001493152-25-022391.md) | [15.6](/filings/0001493152-26-038782.md) | [9.4](/filings/0001493152-26-022779.md) | [9.0](/filings/0001493152-26-038782.md) |
| Shareholders' equity | $m | [4.5](/filings/0001493152-24-046023.md) | [9.7](/filings/0001493152-26-022760.md) | [0.7](/filings/0001493152-25-011913.md) | [18.7](/filings/0001493152-25-022391.md) | [7.7](/filings/0001493152-25-022391.md) | [(3.4)](/filings/0001493152-26-038782.md) | [51.6](/filings/0001493152-26-038782.md) | [36.6](/filings/0001493152-26-038782.md) | [21.6](/filings/0001493152-25-022391.md) | [82.9](/filings/0001493152-26-038782.md) | [71.7](/filings/0001493152-26-038782.md) | [61.7](/filings/0001493152-26-038782.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(9.6) d](/filings/0001493152-24-046023.md) | [(5.2) d](/filings/0001641172-25-000043.md) | [(8.5)](/filings/0001641172-25-010011.md) | [(8.2) d](/filings/0001493152-25-011913.md) | [(10.0) d](/filings/0001493152-25-022391.md) | [(10.9) d](/filings/0001493152-26-022760.md) | [(6.3)](/filings/0001493152-26-022779.md) | [(15.4) d](/filings/0001493152-26-038782.md) | [(13.4) d](/filings/0001493152-25-022391.md) | [(12.5) d](/filings/0001493152-26-022760.md) | [(12.2)](/filings/0001493152-26-022779.md) | [(8.9) d](/filings/0001493152-26-038782.md) |
| Capital expenditure | $m | [1.5 d](/filings/0001493152-24-046023.md) | [1.9 d](/filings/0001641172-25-000043.md) | [1.1](/filings/0001641172-25-010011.md) | [0.1 d](/filings/0001493152-25-011913.md) | [0.0 d](/filings/0001493152-25-022391.md) | [(0.1) d](/filings/0001493152-26-022760.md) | [0.1](/filings/0001493152-26-022779.md) | [1.5 d](/filings/0001493152-26-038782.md) | [0.2 d](/filings/0001493152-25-022391.md) | [1.1 d](/filings/0001493152-26-022760.md) | [0.8](/filings/0001493152-26-022779.md) | [0.0 d](/filings/0001493152-26-038782.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2023-03-31) | period not labelled (2023-06-30) | period not labelled (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [118](/filings/0001104659-24-079535.md) | [121](/filings/0001493152-24-033164.md) | [136](/filings/0001493152-24-046023.md) | [149](/filings/0001641172-25-010011.md) | [7.7](/filings/0001493152-25-011913.md) | [9.3](/filings/0001493152-25-022391.md) | [11.2](/filings/0001493152-26-022779.md) | [21.4](/filings/0001493152-26-038782.md) | [21.5](/filings/0001493152-25-022391.md) | [35.5](/filings/0001493152-26-022779.md) | [35.6](/filings/0001493152-26-038782.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 35,648,164 at 2026-08-17, from the cover of the [10-Q filed 2026-08-17](/filings/0001493152-26-038782.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.